You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Long‐term follow‐up of children with high‐risk neuroblastoma: The ENSG5 trial experience
|
|---|---|
| Published in |
Pediatric Blood and Cancer, December 2012
|
| DOI | 10.1002/pbc.24452 |
| Pubmed ID | |
| Authors |
Lucas Moreno, Sucheta J. Vaidya, C. Ross Pinkerton, Ian J. Lewis, John Imeson, David Machin, Andrew D. J. Pearson, on behalf of the European Neuroblastoma Study Group and the Children's Cancer and Leukaemia Group |
| Abstract |
Therapy for high-risk neuroblastoma is intensive and multimodal, and significant long-term adverse effects have been described. The aim of this study was to identify the nature and severity of late complications of metastatic neuroblastoma survivors included in the ENSG5 clinical trial. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 1% |
| Belgium | 1 | 1% |
| Unknown | 68 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 14 | 20% |
| Student > Bachelor | 10 | 14% |
| Other | 5 | 7% |
| Researcher | 5 | 7% |
| Student > Doctoral Student | 5 | 7% |
| Other | 18 | 26% |
| Unknown | 13 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 39 | 56% |
| Nursing and Health Professions | 5 | 7% |
| Agricultural and Biological Sciences | 4 | 6% |
| Biochemistry, Genetics and Molecular Biology | 2 | 3% |
| Unspecified | 2 | 3% |
| Other | 3 | 4% |
| Unknown | 15 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 May 2013.
All research outputs
#19,962,154
of 25,394,764 outputs
Outputs from Pediatric Blood and Cancer
#3,897
of 6,048 outputs
Outputs of similar age
#221,441
of 289,022 outputs
Outputs of similar age from Pediatric Blood and Cancer
#34
of 53 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,048 research outputs from this source. They receive a mean Attention Score of 3.7. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 289,022 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.